Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
PHASE4
Multicentric study, open, single arm, designed to evaluate the efficacy(res...
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
PHASE3
Thalidomide-Dexamethasone (TD) is a standard induction therapy for Multiple...
Status
Unknown
Location
AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
PHASE2
RATIONALE: Sometimes the cancer may not need treatment until it progresses....
Status
Withdrawn
Location
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center